0001104659-21-086990.txt : 20210629 0001104659-21-086990.hdr.sgml : 20210629 20210629191120 ACCESSION NUMBER: 0001104659-21-086990 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210625 FILED AS OF DATE: 20210629 DATE AS OF CHANGE: 20210629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRINT PAUL C CENTRAL INDEX KEY: 0001236548 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39676 FILM NUMBER: 211059682 MAIL ADDRESS: STREET 1: 7757 DOUGHILL COURT CITY: SAN DIEGO STATE: CA ZIP: 92127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc. CENTRAL INDEX KEY: 0001750149 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 678-392-3419 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 4 1 tm2120992d3_4.xml OWNERSHIP DOCUMENT X0306 4 2021-06-25 0 0001750149 Inhibikase Therapeutics, Inc. IKT 0001236548 GRINT PAUL C 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 1 0 0 0 Stock Option (right to buy) 2.92 2021-06-25 4 A 0 22677 0 A 2022-06-25 2028-06-25 Common Stock 22677 22677 D /s/ Milton H. Werner, attorney-in-fact 2021-06-29